Category Archives: Cancer and neoplasms

New study findings suggest that there are discrepancies between patient- and clinician-reported comorbidities and symptoms in breast cancer. Comorbidities and symptoms in patients with metastatic breast cancer can impact treatment options, eligibility for clinical trials, and influence prognosis and quality of life. It is unclear whether physician documentation or patient-reported symptoms and health conditions more […]

503B Compounding Pharmacy ADHD Allergy Alzheimer Disease Anxiety Asthma Atopic Dermatitis Biosimilars Bipolar Disorder Brain Health Breast Cancer C. Difficile COPD COVID Treatment Cardiovascular Health Cervical Cancer Cholangiocarcinoma Chronic Kidney Disease Chronic Lymphocytic Leukemia Colorectal Cancer Coronavirus Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy […]

Specialty

Specialty

Abstract The phenomenon of platinum resistance is a very serious problem in the treatment of ovarian cancer. Unfortunately, no molecular, genetic marker that could be used in assigning women suffering from ovarian cancer to the platinum-resistant or platinum-sensitive group has been discovered so far. Therefore, in this study, for the first time, we used FT-Raman […]

Understanding Different Types Of Haematological Malignancies Haematological malignancies, commonly known as blood cancers, encompass a diverse group of diseases affecting the blood, bone marrow and lymphatic system. Cleveland Clinic defines blood cancer as “Blood cancer affects how your body produces blood cells and how well those cells work. Most blood cancers start in your bone […]

Abstract Current therapies for myeloproliferative neoplasms (MPNs) improve symptoms but have limited effect on tumor size. In preclinical studies, tamoxifen restored normal apoptosis in mutated hematopoietic stem/progenitor cells (HSPCs). TAMARIN Phase-II, multicenter, single-arm clinical trial assessed tamoxifen’s safety and activity in patients with stable MPNs, no prior thrombotic events and mutated JAK2V617F, CALRins5 or CALRdel52 […]

Whenever I give talks, I often ask the audience to raise their hands if they have had to seek medical attention. Naturally, many hands go up. I then ask attendees to keep their hands raised if their provider asks about early childhood adversities, workplace conditions, their relationship with supervisors, any recent challenges at work, overall […]

Investigators Highlight Benefits of Outpatient Delivery of Intensive Chemotherapy Findings from a 5-year quality improvement project suggest that intensive chemotherapy can be safely and effectively delivered in the outpatient setting for patients with hematological malignancies, according to a poster presented during the 2023 ASCO Quality Care Symposium. “Outpatient delivery of intensive chemotherapy for hematological malignancies […]